e150 13th International Congress on Infectious Diseases Abstracts, Poster Presentations 19.026 Co-Administration of GSK's AS04
Booster vaccination at 6-8 years of age with a reduced antigen content dTpa- IPV vaccine is immunogenic and safe after priming with whole-cell pertussis vaccine: Human Vaccines: Vol 4, No 1
![PDF) A phase III, open-label, randomised multicentre study to evaluate the immunogenicity and safety of a booster dose of two different reduced antigen diphtheria-tetanus-acellular pertussis-polio vaccines, when co-administered with measles-mumps ... PDF) A phase III, open-label, randomised multicentre study to evaluate the immunogenicity and safety of a booster dose of two different reduced antigen diphtheria-tetanus-acellular pertussis-polio vaccines, when co-administered with measles-mumps ...](https://www.researchgate.net/publication/323867974/figure/fig1/AS:867689169948678@1583884627878/Participant-flow-chart-ATP-according-to-protocol-dTap-IPVB-reduced_Q320.jpg)
PDF) A phase III, open-label, randomised multicentre study to evaluate the immunogenicity and safety of a booster dose of two different reduced antigen diphtheria-tetanus-acellular pertussis-polio vaccines, when co-administered with measles-mumps ...
![Diphtheria, tetanus, and pertussis immunization in children 6 weeks through 6 years of age - UpToDate Diphtheria, tetanus, and pertussis immunization in children 6 weeks through 6 years of age - UpToDate](https://www.uptodate.com/contents/images/PEDS/82617/Childhdimmnztnschd06yrs.gif)